In conclusion, this mini review makes the case that there are some similarities between IL-37 and IL-38 in inhibiting tumorigenesis of CRC, yet these two interleukins use different signaling pathways in mediating and/or interacting with cancer cells in the tumor microenvironment. The gene discussed is IL37; the disease is neoplasm.